BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Quarterly figures for BioMarin Pharmaceutical Inc, with source filings when available.
69 quarters. Jun 30, 2009 to Jun 30, 2026. USD.
BioMarin Pharmaceutical Inc has filed its 10-Q within 26 to 37 days of period end across its last 8 quarters. The 10-K runs 55 to 59 days.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $989.71M | +19.9% | $0.23 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 4, 2026 · after-hours |
| May 5, 2026 |
| 35 d |
| 10-Q |
| $766.21M |
| +2.8% |
| $0.54 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 23, 2026 · after-hours | Feb 26, 2026 | 57 d | 10-K | $874.57M | +17.0% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 27, 2025 · after-hours | Oct 28, 2025 | 28 d | 10-Q | $776.13M | +4.1% | -$0.16 | |
| Q2 2025 | Jun 30, 2025 | Aug 4, 2025 · after-hours | Aug 5, 2025 | 36 d | 10-Q | $825.41M | +15.9% | $1.23 | |
| Q1 2025 | Mar 31, 2025 | May 1, 2025 · after-hours | May 2, 2025 | 32 d | 10-Q | $745.15M | +14.8% | $0.95 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 19, 2025 · after-hours | Feb 24, 2025 | 55 d | 10-K | $747.31M | +15.6% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 29, 2024 · after-hours | Oct 31, 2024 | 31 d | 10-Q | $745.74M | +28.3% | $0.55 | |
| Q2 2024 | Jun 30, 2024 | Aug 5, 2024 · after-hours | Aug 5, 2024 | 36 d | 10-Q | $712.03M | +19.6% | $0.55 | |
| Q1 2024 | Mar 31, 2024 | Apr 24, 2024 · after-hours | Apr 26, 2024 | 26 d | 10-Q | $648.83M | +8.8% | $0.46 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 22, 2024 · after-hours | Feb 26, 2024 | 57 d | 10-K | $646.21M | +20.2% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 1, 2023 · after-hours | Nov 2, 2023 | 33 d | 10-Q | $581.33M | +15.0% | $0.21 | |
| Q2 2023 | Jun 30, 2023 | Jul 31, 2023 · after-hours | Aug 2, 2023 | 33 d | 10-Q | $595.28M | +11.5% | $0.29 | |
| Q1 2023 | Mar 31, 2023 | Apr 26, 2023 · after-hours | Apr 28, 2023 | 28 d | 10-Q | $596.42M | +14.8% | $0.27 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 27, 2023 · after-hours | Feb 27, 2023 | 58 d | 10-K | $537.54M | +19.5% | — | |
| Q3 2022 | Sep 30, 2022 | Oct 26, 2022 · after-hours | Oct 28, 2022 | 28 d | 10-Q | $505.34M | +23.6% | -$0.04 | |
| Q2 2022 | Jun 30, 2022 | Aug 3, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $533.80M | +6.4% | $0.15 | |
| Q1 2022 | Mar 31, 2022 | Apr 27, 2022 · after-hours | Apr 29, 2022 | 29 d | 10-Q | $519.36M | +6.9% | $0.63 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 23, 2022 · after-hours | Feb 25, 2022 | 56 d | 10-K | $449.81M | −0.5% | — | |
| Q3 2021 | Sep 30, 2021 | Oct 27, 2021 · after-hours | Oct 29, 2021 | 29 d | 10-Q | $408.74M | −14.3% | -$0.20 | |
| Q2 2021 | Jun 30, 2021 | Jul 28, 2021 · after-hours | Jul 30, 2021 | 30 d | 10-Q | $501.69M | +16.8% | $0.07 | |
| Q1 2021 | Mar 31, 2021 | Apr 29, 2021 · after-hours | Apr 30, 2021 | 30 d | 10-Q | $486.03M | −3.2% | $0.09 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Feb 25, 2021 · after-hours | Feb 26, 2021 | 57 d | 10-K | $452.12M | −0.5% | — | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · after-hours | Nov 6, 2020 | 37 d | 10-Q | $476.78M | +3.4% | $4.01 | |
| Q2 2020 | Jun 30, 2020 | Aug 4, 2020 · after-hours | Aug 5, 2020 | 36 d | 10-Q | $429.49M | +10.8% | -$0.16 | |
| Q1 2020 | Mar 31, 2020 | Apr 29, 2020 · after-hours | May 1, 2020 | 31 d | 10-Q | $502.07M | +25.3% | $0.44 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | Feb 26, 2020 · after-hours | Feb 27, 2020 | 58 d | 10-K | $454.44M | +28.7% | — | |
| Q3 2019 | Sep 30, 2019 | Oct 23, 2019 · after-hours | Oct 29, 2019 | 29 d | 10-Q | $461.10M | +17.7% | $0.30 | |
| Q2 2019 | Jun 30, 2019 | Aug 1, 2019 · after-hours | Aug 2, 2019 | 33 d | 10-Q | $387.76M | +4.0% | -$0.21 | |
| Q1 2019 | Mar 31, 2019 | Apr 25, 2019 · after-hours | Apr 29, 2019 | 29 d | 10-Q | $400.75M | +7.3% | -$0.32 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | Feb 21, 2019 · after-hours | Feb 28, 2019 | 59 d | 10-K | $353.21M | −1.4% | — | |
| Q3 2018 | Sep 30, 2018 | Oct 25, 2018 · after-hours | Oct 26, 2018 | 26 d | 10-Q | $391.71M | +17.2% | -$0.07 | |
| Q2 2018 | Jun 30, 2018 | Aug 2, 2018 · after-hours | Aug 3, 2018 | 34 d | 10-Q | $372.85M | +17.5% | -$0.09 | |
| Q1 2018 | Mar 31, 2018 | Apr 25, 2018 · after-hours | Apr 27, 2018 | 27 d | 10-Q | $373.45M | +22.9% | -$0.26 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | Feb 22, 2018 · after-hours | Feb 26, 2018 | 57 d | 10-K | $358.31M | +19.4% | — | |
| Q3 2017 | Sep 30, 2017 | — | Oct 31, 2017 | 31 d | 10-Q | $334.15M | +19.4% | -$0.07 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 2, 2017 | 33 d | 10-Q | $317.45M | +5.8% | -$0.21 | |
| Q1 2017 | Mar 31, 2017 | — | May 4, 2017 | 34 d | 10-Q | $303.75M | +28.3% | -$0.09 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Feb 27, 2017 | 58 d | 10-K | $300.09M | +31.7% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 3, 2016 | 34 d | 10-Q | $279.90M | +34.0% | -$0.22 | |
| Q2 2016 | Jun 30, 2016 | — | — | — | — | $300.13M | +20.0% | -$2.58 | |
| Q1 2016 | Mar 31, 2016 | — | — | — | — | $236.74M | +16.7% | -$0.51 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | — | — | — | $227.94M | −0.6% | — | |
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $208.90M | +18.3% | -$0.60 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $250.14M | +30.4% | -$0.51 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $202.92M | +33.9% | -$0.43 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | — | — | — | $229.40M | +56.2% | — | |
| Q3 2014 | Sep 30, 2014 | — | Oct 28, 2014 | 28 d | 10-Q | $176.55M | +29.0% | $0.05 | |
| Q2 2014 | Jun 30, 2014 | — | Jul 31, 2014 | 31 d | 10-Q | $191.79M | +40.2% | -$0.23 | |
| Q1 2014 | Mar 31, 2014 | — | May 2, 2014 | 32 d | 10-Q | $151.55M | +18.5% | -$0.27 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | — | — | — | $146.87M | +11.3% | — | |
| Q3 2013 | Sep 30, 2013 | — | Oct 28, 2013 | 28 d | 10-Q | $136.87M | +6.8% | -$0.38 | |
| Q2 2013 | Jun 30, 2013 | — | Jul 29, 2013 | 29 d | 10-Q | $136.81M | +10.3% | -$0.16 | |
| Q1 2013 | Mar 31, 2013 | — | Apr 29, 2013 | 29 d | 10-Q | $127.93M | +9.7% | -$0.31 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | — | — | — | $131.94M | +22.3% | — | |
| Q3 2012 | Sep 30, 2012 | — | Oct 29, 2012 | 29 d | 10-Q | $128.12M | +13.0% | -$0.04 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 2, 2012 | 33 d | 10-Q | $124.02M | +12.1% | -$0.27 | |
| Q1 2012 | Mar 31, 2012 | — | Apr 30, 2012 | 30 d | 10-Q | $116.65M | +6.6% | -$0.21 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | — | — | — | $107.85M | +6.1% | — | |
| Q3 2011 | Sep 30, 2011 | — | Oct 31, 2011 | 31 d | 10-Q | $113.43M | +16.0% | -$0.16 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 1, 2011 | 32 d | 10-Q | $110.63M | +20.3% | -$0.05 | |
| Q1 2011 | Mar 31, 2011 | — | Apr 29, 2011 | 29 d | 10-Q | $109.46M | +28.8% | -$0.04 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | $101.61M | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $97.75M | +21.0% | $1.68 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $91.95M | +11.1% | -$0.01 | |
| Q1 2010 | Mar 31, 2010 | — | — | — | — | $84.95M | — | — | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009derived | Dec 31, 2009 | — | — | — | — | — | — | — | |
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $80.81M | — | $0.07 | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $82.79M | — | $0.01 | |